Abstract Carbohydrate antigen 19-9 (CA 19-9) is a cell surface glycoprotein complex most
commonly associated with pancreatic ductal adenocarcinoma (PDAC). Koprowski first …

Lung cancer is the second most commonly diagnosed cancer in the world. In terms of the
diagnosis of lung cancer, combination carcinoembryonic antigen (CEA) and cancer antigen …

Background There is currently a lack of effective biomarkers to evaluate efficacy of
neoadjuvant therapy (NAT) for resectable non-small cell lung cancer (NSCLC) patients …

Circulating tumor DNA (ctDNA) in peripheral blood is a “liquid biopsy” that contains
representative tumor information including gene mutations. Additionally, repeated ctDNA …

Purpose Circulating microRNAs (miRNAs) have shown the potential for non-invasive
diagnosis of various types of malignancies at an early stage. The aim of the study was to …

Purpose: MUC16, a tumor biomarker and cell surface–associated mucin, is overexpressed
in various cancers; however, its role in lung cancer pathogenesis is unknown. Here, we …

Lung cancer is the most frequently occurring cancer in the world and continually leads in
mortality among cancers. The overall 5-year survival rate for lung cancer has risen only …

The aim of this study was to investigate the prognostic value of tumor markers in operable
non-small cell lung cancer (NSCLC) patients. A total of 481 NSCLC patients were enrolled …

Simple Summary Non-small-cell lung cancer (NSCLC) accounts for approximately 85% of
all lung cancers, and the postoperative survival of early-stage NSCLC patients remains …

Serum biomarkers provide valuable information about the diagnosis and prognosis of a
wide variety of malignant tumors. Despite the identification of several useful serum …